CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 42 enrolled
Drug / intervention
Flavoring Agents +1 moredrug
Likely dose
Nicotine 36 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03634839
NCT03634839Phase 1Completed

Effects of E-cigarette Flavors on Youth

Yale University·interventional·Posted Aug 17, 2018·Updated Aug 9, 2024

In Brief

A Phase 1 clinical trial evaluating Flavoring Agents and Nicotine for Nicotine Use Disorder. Completed, enrolled 42 participants across 1 site.

Detailed Summary

This study is an examination of the influence of sweet and cooling flavors on the appeal and abuse potential of nicotine-containing e-cigarettes among susceptible youth.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 1CompletedFinished
20192020202120222023202420252026
First PostedAug 17, 2018
Enrollment StartNov 7, 2022
Primary CompletionJun 16, 2023
Study CompletionJul 20, 2023
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.9 years ago

Interventions

Flavoring Agentsdrug

Flavor of e-liquid - sweet or tobacco

Nicotinedrug

Nicotine level (36 mg/ml)